| Detected | Trial | Change |
|---|---|---|
| 2026-06-05 | NCT03919240 CAR-T Cell Therapy Targeting to CD19 for R/R ALL |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-14 | NCT07538635 CAR-T Combined With ASCT in the Treatment of Relapsed/Refractory Large B-cell Lymphoma… |
Recruitment opened |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07479797 | Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants… | Relapsed or Refractory Large B-cell Lymphoma | Recruiting |
| NCT07188558 | A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy | Large B-cell Lymphoma | Recruiting |
| NCT05605899 | Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line… | High-risk Large B-cell Lymphoma (LBCL) | Active, Not Recruiting |
| Phase 2 | |||
| NCT06213311 | A Study of Axicabtagene Ciloleucel and Glofitamab as Second-Line Therapy for Relapsed or… | B Cell Lymphoma | Recruiting |
| NCT05633615 | Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory… | Diffuse Large B-Cell Lymphoma | Recruiting |
| NCT07042438 | Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed… | Recurrent Diffuse Large B-Cell Lymphoma | Recruiting |
| NCT05757219 | Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy | Diffuse Large B Cell Lymphoma | Recruiting |
| NCT06144606 | Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic… | B-Cell Lymphoblastic Leukemia | Recruiting |
| NCT06553872 | Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R… | Mantle Cell Lymphoma | Recruiting |
| NCT06043323 | A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR)… | Follicular Lymphoma | Recruiting |
| NCT07538635 | CAR-T Combined With ASCT in the Treatment of Relapsed/Refractory Large B-cell Lymphoma… | High-risk R/R LBCL | Recruiting |
| NCT07326371 | Glofitamab Combined With CAR-T Therapy in R/R DLBCL | DLBCL - Diffuse Large B Cell Lymphoma | Not Yet Recruiting |
| NCT03642626 | MT2017-45: CAR-T Cell Therapy for Heme Malignancies | Acute Lymphoblastic Leukemia | Active, Not Recruiting |
| NCT04531046 | Axi-Cel as a 2nd Line Therapy in Patients With Relapsed/Refractory Aggressive B Lymphoma… | B-Cell Lymphoma Refractory | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT03919240 | CAR-T Cell Therapy Targeting to CD19 for R/R ALL | Acute Lymphoblastic Leukemia With Failed Remission | Active, Not Recruiting |
| Phase 1 | |||
| NCT05077527 | Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin… | AIDS-Related Diffuse Large B-cell Lymphoma | Recruiting |
| NCT07052305 | NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or… | Large B-cell Lymphoma | Recruiting |
| Not specified | |||
| NCT05041309 | Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies… | Solid and Hematological Malignancies | Enrolling by Invitation |